HEC Pharm Announces 2018 Interim Results

Profits attributable to shareholders increased significantly by 110.2% to RMB 634.5 million; Sales of core drugs continued to record strong growth Strategic investment by leading international investment firm Blackstone to support the company's future growth HONG KONG, Aug. 24, 2018 /PRNewswire/...